IIM
INTECH Investment Management Portfolio holdings
AUM
$10.7B
1-Year Return
23.47%
This Quarter Return
+4.48%
1 Year Return
+23.47%
3 Year Return
+97.82%
5 Year Return
–
10 Year Return
–
AUM
$10.3B
AUM Growth
+$1.38B
(+15%)
Cap. Flow
+$1.22B
Cap. Flow
% of AUM
11.8%
Top 10 Holdings %
Top 10 Hldgs %
25.81%
Holding
2,444
New
431
Increased
1,575
Reduced
361
Closed
67
Top Buys
| 1 |
Broadcom
AVGO
|
$49.6M |
| 2 |
Palantir
PLTR
|
$47.1M |
| 3 |
Merck
MRK
|
$46.5M |
| 4 |
Wells Fargo
WFC
|
$41M |
| 5 |
Centene
CNC
|
$40.7M |
Top Sells
| 1 |
Apple
AAPL
|
$116M |
| 2 |
Amazon
AMZN
|
$83.5M |
| 3 |
Vanguard Russell 2000 ETF
VTWO
|
$64.9M |
| 4 |
Deckers Outdoor
DECK
|
$47.3M |
| 5 |
Microsoft
MSFT
|
$43.7M |
Sector Composition
| 1 | Technology | 27.33% |
| 2 | Financials | 13.81% |
| 3 | Healthcare | 12.67% |
| 4 | Industrials | 10.75% |
| 5 | Consumer Discretionary | 10.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Commercial Vehicle Group
CVGI
$68.1M
| $38.5K | ﹤0.01% |
+15,508
| New | +$38.5K |
|
2352
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $38.1K | ﹤0.01% |
+27,600
| New | +$38.1K |
|
2353
LiveOne
LVO
$51.2M
| $37.6K | ﹤0.01% |
+25,564
| New | +$37.6K |
|
2354
1stdibs.com
DIBS
$100M
| $35.9K | ﹤0.01% |
+10,143
| New | +$35.9K |
|
2355
Harvard Bioscience
HBIO
$21.3M
| $35.4K | ﹤0.01% |
+16,797
| New | +$35.4K |
|
2356
Nautilus Biotechnolgy
NAUT
$83.5M
| $35.2K | ﹤0.01% |
+20,951
| New | +$35.2K |
|
2357
Pyxis Oncology
PYXS
$118M
| $35.1K | ﹤0.01% |
22,491
+7,594
| +51% | +$11.8K |
|
2358
Holley
HLLY
$469M
| $34.4K | ﹤0.01% |
11,375
-2,598
| -19% | -$7.85K |
|
2359
Information Services Group
III
$253M
| $34.2K | ﹤0.01% |
+10,242
| New | +$34.2K |
|
2360
Fractyl Health
GUTS
$65.4M
| $33.8K | ﹤0.01% |
+16,414
| New | +$33.8K |
|
2361
Acumen Pharmaceuticals
ABOS
$87.2M
| $32.4K | ﹤0.01% |
+18,847
| New | +$32.4K |
|
|
AKYA
2362
DELISTED
Akoya BioSciences
AKYA
| $27K | ﹤0.01% |
+11,780
| New | +$27K |
|
2363
HilleVax
HLVX
$105M
| $26.2K | ﹤0.01% |
+12,647
| New | +$26.2K |
|
2364
FibroBiologics
FBLG
$24.1M
| $25.3K | ﹤0.01% |
+12,653
| New | +$25.3K |
|
2365
Generation Bio
GBIO
$40.3M
| $24.7K | ﹤0.01% |
+2,334
| New | +$24.7K |
|
|
CLYM
2366
Climb Bio, Inc. Common Stock
CLYM
$162M
| $24.7K | ﹤0.01% |
+13,701
| New | +$24.7K |
|
2367
908 Devices
MASS
$196M
| $23.9K | ﹤0.01% |
+10,885
| New | +$23.9K |
|
2368
RAPT Therapeutics
RAPT
$214M
| $23.3K | ﹤0.01% |
+1,844
| New | +$23.3K |
|
2369
Century Therapeutics
IPSC
$43.6M
| $23.1K | ﹤0.01% |
+22,892
| New | +$23.1K |
|
2370
Ovid Therapeutics
OVID
$87.5M
| $22.2K | ﹤0.01% |
+23,724
| New | +$22.2K |
|
2371
ALX Oncology
ALXO
$65.3M
| $22K | ﹤0.01% |
+13,198
| New | +$22K |
|
2372
Werewolf Therapeutics
HOWL
$61.7M
| $22K | ﹤0.01% |
+14,866
| New | +$22K |
|
2373
Inovio Pharmaceuticals
INO
$148M
| $22K | ﹤0.01% |
+12,007
| New | +$22K |
|
2374
Shattuck Labs
STTK
$74.2M
| $21.8K | ﹤0.01% |
+18,012
| New | +$21.8K |
|
2375
Actinium Pharmaceuticals
ATNM
$49.3M
| $17.9K | ﹤0.01% |
+14,198
| New | +$17.9K |
|